Geode Capital Management’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-494,234
Closed -$4.65M 4336
2020
Q3
$4.65M Sell
494,234
-5,682
-1% -$53.4K ﹤0.01% 2434
2020
Q2
$3.82M Sell
499,916
-571
-0.1% -$4.37K ﹤0.01% 2493
2020
Q1
$3.09M Buy
500,487
+25,861
+5% +$160K ﹤0.01% 2427
2019
Q4
$5.78M Buy
474,626
+16,607
+4% +$202K ﹤0.01% 2362
2019
Q3
$5.29M Buy
458,019
+1,353
+0.3% +$15.6K ﹤0.01% 2352
2019
Q2
$4.56M Sell
456,666
-18,421
-4% -$184K ﹤0.01% 2458
2019
Q1
$6.12M Buy
475,087
+40,282
+9% +$519K ﹤0.01% 2215
2018
Q4
$6.6M Sell
434,805
-683
-0.2% -$10.4K ﹤0.01% 2052
2018
Q3
$8.71M Buy
435,488
+31,038
+8% +$621K ﹤0.01% 2029
2018
Q2
$7.89M Buy
404,450
+34,894
+9% +$680K ﹤0.01% 2056
2018
Q1
$7.45M Sell
369,556
-7,923
-2% -$160K ﹤0.01% 1981
2017
Q4
$5M Buy
377,479
+5,452
+1% +$72.2K ﹤0.01% 2215
2017
Q3
$6.86M Buy
372,027
+8,709
+2% +$161K ﹤0.01% 2005
2017
Q2
$6.68M Buy
363,318
+830
+0.2% +$15.3K ﹤0.01% 1948
2017
Q1
$8.17M Buy
362,488
+56,493
+18% +$1.27M ﹤0.01% 1758
2016
Q4
$10.6M Buy
305,995
+15,010
+5% +$522K 0.01% 1523
2016
Q3
$7.13M Buy
290,985
+7,336
+3% +$180K ﹤0.01% 1718
2016
Q2
$6.78M Buy
283,649
+20,801
+8% +$497K ﹤0.01% 1697
2016
Q1
$6.15K Buy
262,848
+10,067
+4% +$236 ﹤0.01% 1738
2015
Q4
$7.63M Buy
252,781
+17,850
+8% +$539K ﹤0.01% 1570
2015
Q3
$9.33M Buy
234,931
+36,722
+19% +$1.46M 0.01% 1391
2015
Q2
$13.7M Buy
198,209
+25,241
+15% +$1.74M 0.01% 1198
2015
Q1
$9.45M Buy
172,968
+43,113
+33% +$2.36M 0.01% 1432
2014
Q4
$5.53M Buy
129,855
+3,133
+2% +$133K ﹤0.01% 1750
2014
Q3
$4.04M Buy
126,722
+2,213
+2% +$70.6K ﹤0.01% 1897
2014
Q2
$2.58M Buy
124,509
+4,165
+3% +$86.3K ﹤0.01% 2218
2014
Q1
$2.33M Buy
120,344
+3,230
+3% +$62.5K ﹤0.01% 2247
2013
Q4
$2.84M Buy
117,114
+7,825
+7% +$190K ﹤0.01% 2090
2013
Q3
$2.35M Buy
109,289
+2,971
+3% +$63.8K ﹤0.01% 2074
2013
Q2
$2.37M Buy
+106,318
New +$2.37M ﹤0.01% 1942